In addition it addresses the FDA’s communications Along with the applicant, the retention of information that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer ownership of the SE report back to a new applicant and electronic submission in the SE report and